Nina Kjellson

Nina Kjellson is a General Partner at Canaan Partners and serves on the boards of several companies, including Actio Biosciences, Inc., Proxygen, Rondo Therapeutics, and Sardona Therapeutics. Nina Kjellson obtained a Bachelor of Arts in Human Biology from Stanford University, where studies were completed between 1992 and 1997, and received primary education at Phillips Exeter Academy.